Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome

Purpose. To report the long-term outcomes of patients with iridocorneal end othelial (ICE) syndrome who required surgery for glaucoma. Design: Retrospective, noncomparative case series. Participants: Twenty-six patients with ICE syndrome who underwent surgery f or glaucoma at one institution between January 1987 and January 2000. Main Outcome Measures: Intraocular pressure (IOP), visual acuity, number of glaucoma medications, and further surgical interventions were measured. Results: Five eyes had a trabeculectomy with an antifibrotic agent alone, s even eyes had a trabeculectomy with an antifibrotic agent and a subsequent glaucoma drainage implant (GDI), and 14 eyes had a GDI alone. In eyes that underwent a trabeculectomy with an antifibrotic agent, preoperative IOP was reduced from a mean of 38.8 +/- 10.5 mmHg on 2.3 +/- 0.8 glaucoma medicati ons to a mean of 11.8 +/- 4.3 mmHg on 1.2 +/- 1.4 medications at last follo w-up after surgery (83.8 +/- 40.3 months). In eyes that underwent GDI surge ry, preoperative IOP was reduced from a mean of 35.2 +/- 13.0 mmHg on 2.0 /- 1.3 glaucoma medications to a mean of 8.7 +/- 11.2 mmHg on 1.2 +/- 1.1 m edications at last follow-up after surgery (50.5 +/- 40.7 months). Twenty-f our eyes (92%) had an IOP less than 22 mmHg, and 22 eyes (85%) had visual a cuity 20/400 or better at last follow-up (55.8 +/- 41.5 months). Mean numbe r of glaucoma surgeries per patient over the follow-up period was 1.6 +/- 1 .2. Trabeculectomy with antifibrotic agents had a survival of 73% at 1 year , 44% at 3 years, and 29% at 5 years. Glaucoma drainage implants had a surv ival of 71% at 1 year, 71% at 3 years, and 53% at 5 years. Conclusions: Glaucoma associated with ICE syndrome can be managed successfu lly surgically, although multiple procedures are often needed. Ophthalmolog y 2001;108:1789-1795 (C) 2001 by the American Academy of Ophthalmology.